Title:
Anticancer compounds derived from fungal endophytes: Their importance and future challenges

dc.contributor.authorRavindra N. Kharwar
dc.contributor.authorAshish Mishra
dc.contributor.authorSurendra K. Gond
dc.contributor.authorAndrea Stierle
dc.contributor.authorDonald Stierle
dc.date.accessioned2026-02-07T05:26:00Z
dc.date.issued2011
dc.description.abstractThis is a review of anticancer agents isolated from endophytic fungi from 1990-2010. Endophytic fungi are defined as fungi that live asymptomatically within the tissues of higher plants. The designation 'anticancer' is based on the assessment of the authors of the paper of the cytotoxicity of each compound against specific cancer cell lines. Many of the compounds reported here were isolated exclusively from endophytes in culture, while other compounds had been previously reported as chemical constituents of higher plants. The uniqueness of the endophytic community of fungi is stressed as a promising source of novel compounds with anticancer activity, or as an alternative source of compounds originally isolated from higher plants. Endophytes represent a dependable source of specific secondary metabolites, and can be manipulated both physicochemically and genetically to increase yields of desired metabolites and to produce novel analogues of active metabolites. © 2011 The Royal Society of Chemistry.
dc.identifier.doi10.1039/c1np00008j
dc.identifier.issn14604752
dc.identifier.urihttps://doi.org/10.1039/c1np00008j
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/22357
dc.titleAnticancer compounds derived from fungal endophytes: Their importance and future challenges
dc.typePublication
dspace.entity.typeReview

Files

Collections